Showing results (1761-1770 of 14,263) with videos related to
Sort By:
Pageof 1,427
Diabetes|May 1, 1996
LY290181, an inhibitor of diabetes-induced vascular dysfunction, blocks protein kinase C-stimulated transcriptional activation through inhibition of transcription factor binding to a phorbol response elementK A Birch, W F Heath, R N Hermeling, et al.Diabetes|May 1, 1996
Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjectsM Halberstam, N Cohen, P Shlimovich, et al.Diabetes|May 1, 1996
Plasma leptin and insulin relationships in obese and nonobese humansS Dagogo-Jack, C Fanelli, D Paramore, et al.Diabetes|April 1, 1996
Polymorphism at the rad gene is not associated with NIDDM in FinnsM Orho, M Carlsson, T Kanninen, et al.Diabetes|April 1, 1996
Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complicationsH Andersen, P L Poulsen, C E Mogensen, et al.Diabetes|April 1, 1996
Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious ratsJ K Kim, J K Wi, J H YounDiabetes|April 1, 1996
Hyperglucagonemia stimulates phenylalanine oxidation in humansP Tessari, S Inchiostro, R Barazzoni, et al.Diabetes|April 1, 1996
Gene expression of islet cell antigen p69 in human, mouse, and ratW Karges, M Pietropaolo, C A Ackerley, et al.Diabetes|February 1, 1993
Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formationR G Tilton, K Chang, K S Hasan, et al.Pageof 1,427